Annual report
4978.TEDINET S100W6LK
Period2024-04-01 → 2025-03-31
Filed2025-06-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 134
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥2.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥3.0bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | −¥130m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | −¥409m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥45m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥40m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥120m | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥507m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥789m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥45m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥29m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥103m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥31m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥305m | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥575m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥813m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥103m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | −¥31m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥9.7bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥9.1bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥8.4bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥8.1bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥6.0bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥686m | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥741m | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥9.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.3bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.6bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥5.4bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.8bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥6m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥11m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥141m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥246m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥649m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥796m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥404m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥680m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥544m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥483m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥1.11 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.37 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.62 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.57 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-11.38 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥94.89 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥93.41 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥89.01 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥88.11 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥75.17 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 92.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.7% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.5% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.0% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 1.2% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 99 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 96 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 92 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 98 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 106 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥960m | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥941m | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥1.6bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥606m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥401m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | −¥387m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | −¥285m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥62m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥112m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥382m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥559m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥304m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥203m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | −¥306m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | −¥205m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥297m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥541m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥997m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥9.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥8.8bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥8.4bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.2bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥6.1bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥368m | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥408m | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥8.6bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥8.4bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.9bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥7.5bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥5.7bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.6bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-3.29 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.4 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.52 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.13 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.96 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥91.29 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥94.05 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥92.42 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥91.73 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥79.12 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 95.9% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.3% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.8% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.1% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.1% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 94,802,891 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 89,013,591 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,141,191 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 82,270,891 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 71,667,391 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 28 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 26 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 28 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 31 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 34 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥5m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥8.7bn |
| Reconciling Itemsreconciling | segment ordinary income | 2024-04-01 → 2025-03-31 | −¥735m |
| Medical Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥76m |
| Medical Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥25m |
| Medical Businessreportable segment | employees | at 2025-03-31 | 6 pure |
| Medical Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥564m |
| Medical Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥564m |
| Medical Businessreportable segment | segment assets | at 2025-03-31 | ¥363m |
| Medical Businessreportable segment | segment ordinary income | 2024-04-01 → 2025-03-31 | ¥159m |
| Research Support Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥16m |
| Research Support Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥20m |
| Research Support Businessreportable segment | employees | at 2025-03-31 | 69 pure |
| Research Support Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.4bn |
| Research Support Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥2.4bn |
| Research Support Businessreportable segment | segment assets | at 2025-03-31 | ¥646m |
| Research Support Businessreportable segment | segment ordinary income | 2024-04-01 → 2025-03-31 | ¥621m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥91m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥45m |
| —segment total | employees | at 2025-03-31 | 75 pure |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥3.0bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥3.0bn |
| —segment total | segment assets | at 2025-03-31 | ¥1.0bn |
| —segment total | segment ordinary income | 2024-04-01 → 2025-03-31 | ¥780m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥2m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥14m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥8.1bn |
| Reconciling Itemsreconciling | segment ordinary income | 2023-04-01 → 2024-03-31 | −¥626m |
| Medical Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥107m |
| Medical Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥14m |
| Medical Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥347m |
| Medical Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥347m |
| Medical Businessreportable segment | segment assets | at 2024-03-31 | ¥227m |
| Medical Businessreportable segment | segment ordinary income | 2023-04-01 → 2024-03-31 | ¥221m |
| Research Support Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥83m |
| Research Support Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥7m |
| Research Support Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥2.1bn |
| Research Support Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥2.1bn |
| Research Support Businessreportable segment | segment assets | at 2024-03-31 | ¥685m |
| Research Support Businessreportable segment | segment ordinary income | 2023-04-01 → 2024-03-31 | ¥446m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥190m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥21m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥2.4bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥2.4bn |
| —segment total | segment assets | at 2024-03-31 | ¥911m |
| —segment total | segment ordinary income | 2023-04-01 → 2024-03-31 | ¥666m |
| Medical Businessreportable segment | employees | at 2025-03-31 | 6 pure |
| Research Support Businessreportable segment | employees | at 2025-03-31 | 14 pure |
| —segment total | employees | at 2025-03-31 | 20 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,429
| Item | Context | Value | Unit |
|---|---|---|---|
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)楽天証券株式会社 | |
| Address major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)東京都港区南青山２丁目６番２１号 | |
| Name major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Text · Plus | |
| Address major shareholders | CurrentYearInstant_No2MajorShareholdersMember | ONE CHURCHILL PLACE, LONDON, E14 5HP UNITED KINGDOM | |
| Name major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)横山 周史 | |
| Address major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)神奈川県座間市 | |
| Name major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)上田八木短資株式会社 | |
| Address major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)大阪府大阪市中央区高麗橋２丁目４－２ | |
| Name major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)五十畑 輝夫 | |
| Address major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)栃木県栃木市 | |
| Name major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)中野 暁 | |
| Address major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)東京都港区 | |
| Name major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Original text (Japanese)STATE STREET BANK AND TRUST COMPANY 505223（常任代理人 株式会社みずほ銀行） | |
| Address major shareholders | CurrentYearInstant_No7MajorShareholdersMember | P.O. BOX 351 BOSTON MASSACHUSETTS 02101 U.S.A. | |
| Name major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)ＪＰモルガン証券株式会社 | |
| Address major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内２丁目７－３ | |
| Name major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)中辻 憲夫 | |
| Address major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)京都府京都市 | |
| Name major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)椎橋 正則 | |
| Address major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)東京都文京区 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithFullVotingRightsOtherMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であります。また、単元株式数は100株であります。 | |
| Description issued shares voting rights | CurrentYearInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentYearInstant_Row1Member | Original text (Japanese)株式会社リプロセル | |
| Address of shareholder treasury shares etc | CurrentYearInstant_Row1Member | Original text (Japanese)神奈川県横浜市港北区新横浜三丁目８番11号 | |
| Classes of shares etc (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of shareholders meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Disposals or holding of acquired treasury shares (text) | FilingDateInstant | Text · Plus | |
| Dividend policy (text) | FilingDateInstant | Text · Plus | |
| Overview of corporate governance (text) | FilingDateInstant | Text · Plus | |
| Corporate governance company with corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Basic policy regarding control of company (text) | FilingDateInstant | Text · Plus | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E27585-000YokoyamaChikafumiMember | Original text (Japanese)代表取締役社長 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E27585-000YokoyamaChikafumiMember | Original text (Japanese)横山 周史 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E27585-000YokoyamaChikafumiMember | 1968-04-20 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E27585-000YokoyamaChikafumiMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E27585-000YokoyamaChikafumiMember | Original text (Japanese)(注)３ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E27585-000UsuiDaisukeMember | Original text (Japanese)取締役COO | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E27585-000UsuiDaisukeMember | Original text (Japanese)臼井 大祐 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E27585-000UsuiDaisukeMember | 1973-10-21 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E27585-000UsuiDaisukeMember | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |